Krystal Biotech, Inc. - COM (KRYS)

Q2 2024 13F Holders as of 6/30/2024

Type / Class
Equity / COM
Number of holders
247
Total Shares
28.5M
Shares change
+3.59M
Total reported value, excl. options
$5.23B
Value change
+$661M
Put/Call ratio
0.64
Number of buys
149
Number of sells
-107
Price
$183.64
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.